Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
SeptiCyte® RAPID is a gene expression assay measuring the relative expression levels of host response genes PLA2G7 and PLAC8, indicative of a dysregulated immune response during sepsis. As severe forms of COVID-19 may be considered viral sepsis, we evaluated SeptiCyte RAPID in a series of 94 patients admitted to Foch Hospital (Suresnes, France) wit...
Alternative Titles
Full title
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d0e51dc7c82b4b1da23c03ecd9763265
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0e51dc7c82b4b1da23c03ecd9763265
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v15020419
